Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011-20.
John J SchellenbergHeather J AdamMelanie R BaxterJames A KarlowskyAlyssa R GoldenIrene MartinWalter DemczukMichael R MulveyGeorge G ZhanelPublished in: The Journal of antimicrobial chemotherapy (2023)
When compared with PCV13 and PCV15, PCV20 covered significantly more IPD isolates stratified by patient age, region, sex, individual antimicrobial resistance phenotypes and MDR phenotype.